在人 A3 腺苷受体上设计、合成和结合同系物截断的 4'-硫代腺苷衍生物。
Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors.
机构信息
Department of Bioinspired Science, College of Pharmacy, Ewha Womans University, Seoul 120-750, Republic of Korea.
出版信息
Bioorg Med Chem. 2010 Oct 1;18(19):7015-21. doi: 10.1016/j.bmc.2010.08.018. Epub 2010 Aug 14.
Abstract
We synthesized homologated truncated 4'-thioadenosine analogues 3 in which a methylene (CH(2)) group was inserted in place of the glycosidic bond of a potent and selective A(3) adenosine receptor antagonist 2. The analogues were designed to induce maximum binding interaction in the binding site of the A(3) adenosine receptor. However, all homologated nucleosides were devoid of binding affinity at all subtypes of adenosine receptors, indicating that free rotation through the single bond allowed the compound to adopt an indefinite number of conformations, disrupting the favorable binding interaction essential for receptor recognition.
摘要
我们合成了同源截断的 4′-硫代腺苷类似物 3，其中在强效和选择性 A(3) 腺苷受体拮抗剂 2 的糖苷键位置插入了一个亚甲基 (CH(2)) 基团。这些类似物的设计目的是在 A(3) 腺苷受体的结合部位诱导最大的结合相互作用。然而，所有同源化核苷都完全没有对所有亚型的腺苷受体的结合亲和力，这表明通过单键的自由旋转使化合物能够采用无数的构象，破坏了对受体识别至关重要的有利结合相互作用。
相似文献
1
Design, synthesis, and binding of homologated truncated 4'-thioadenosine derivatives at the human A3 adenosine receptors.
Bioorg Med Chem. 2010 Oct 1;18(19):7015-21. doi: 10.1016/j.bmc.2010.08.018. Epub 2010 Aug 14.
2
Stereochemical influence of 4'-methyl substitutions on truncated 4'-thioadenosine derivatives: Impact on A adenosine receptor binding and antagonism.
Bioorg Chem. 2024 Dec;153:107901. doi: 10.1016/j.bioorg.2024.107901. Epub 2024 Oct 19.
3
Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
J Med Chem. 2008 Oct 23;51(20):6609-13. doi: 10.1021/jm8008647. Epub 2008 Sep 24.
4
Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists.
Bioorg Med Chem. 2009 May 15;17(10):3733-8. doi: 10.1016/j.bmc.2009.03.034. Epub 2009 Mar 25.
5
Design and synthesis of truncated 4'-thioadenosine derivatives as potent and selective A3 adenosine receptor antagonists.
Nucleic Acids Symp Ser (Oxf). 2008(52):641-2. doi: 10.1093/nass/nrn324.
6
Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
J Med Chem. 2007 Jul 12;50(14):3159-62. doi: 10.1021/jm070259t. Epub 2007 Jun 8.
7
Correlation study between A adenosine receptor binding affinity and anti-renal interstitial fibrosis activity of truncated adenosine derivatives.
Arch Pharm Res. 2019 Sep;42(9):773-779. doi: 10.1007/s12272-018-1079-2. Epub 2018 Sep 27.
8
Exploring C2 and N Substituent Effects on Truncated 4'-Thioadenosine Derivatives as Dual A and A Adenosine Receptor Ligands.
ChemMedChem. 2025 Feb 16;20(4):e202400575. doi: 10.1002/cmdc.202400575. Epub 2024 Nov 21.
9
Design, synthesis, and anti-tumor activity of 4'-thionucleosides as potent and selective agonists at the human A3 adenosine receptor.
Nucleosides Nucleotides Nucleic Acids. 2007;26(10-12):1565-8. doi: 10.1080/15257770701547107.
10
Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A₂A and A₃ adenosine receptor ligands.
J Med Chem. 2012 Jan 12;55(1):342-56. doi: 10.1021/jm201229j. Epub 2011 Dec 28.
引用本文的文献
1
Synthesis of Nucleoside Analogs Containing Sulfur or Selenium Replacements of the Ribose Ring Oxygen or Carbon.
J Org Chem. 2024 Dec 6;89(23):16977-16989. doi: 10.1021/acs.joc.4c02409. Epub 2024 Nov 21.
2
International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update.
Pharmacol Rev. 2022 Apr;74(2):340-372. doi: 10.1124/pharmrev.121.000445.
3
Discovery and Structure-Activity Relationships of Novel Template, Truncated 1'-Homologated Adenosine Derivatives as Pure Dual PPARγ/δ Modulators.
J Med Chem. 2020 Dec 24;63(24):16012-16027. doi: 10.1021/acs.jmedchem.0c01874. Epub 2020 Dec 16.
4
New HSV-1 Anti-Viral 1'-Homocarbocyclic Nucleoside Analogs with an Optically Active Substituted Bicyclo[2.2.1]Heptane Fragment as a Glycoside Moiety.
Molecules. 2019 Jul 3;24(13):2446. doi: 10.3390/molecules24132446.
5
Synthesis and Binding Affinity of Homologated Adenosine Analogues as A Adenosine Receptor Ligands.
Bull Korean Chem Soc. 2011;32(5):1620-1624. doi: 10.5012/bkcs.2011.32.5.1620.
6
Click modification in the N6 region of A3 adenosine receptor-selective carbocyclic nucleosides for dendrimeric tethering that preserves pharmacophore recognition.
Bioconjug Chem. 2012 Feb 15;23(2):232-47. doi: 10.1021/bc200526c. Epub 2012 Jan 11.
本文引用的文献
1
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist.
Science. 2008 Nov 21;322(5905):1211-7. doi: 10.1126/science.1164772. Epub 2008 Oct 2.
2
Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists.
J Med Chem. 2008 Oct 23;51(20):6609-13. doi: 10.1021/jm8008647. Epub 2008 Sep 24.
3
Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells.
Cancer Lett. 2008 Jun 18;264(2):309-15. doi: 10.1016/j.canlet.2008.01.037. Epub 2008 Mar 5.
4
Discovery of a new nucleoside template for human A3 adenosine receptor ligands: D-4'-thioadenosine derivatives without 4'-hydroxymethyl group as highly potent and selective antagonists.
J Med Chem. 2007 Jul 12;50(14):3159-62. doi: 10.1021/jm070259t. Epub 2007 Jun 8.
5
Docking studies of agonists and antagonists suggest an activation pathway of the A3 adenosine receptor.
J Mol Graph Model. 2006 Dec;25(4):562-77. doi: 10.1016/j.jmgm.2006.05.004. Epub 2006 May 9.
6
Adenosine receptors as therapeutic targets.
Nat Rev Drug Discov. 2006 Mar;5(3):247-64. doi: 10.1038/nrd1983.
7
Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-uronamides as highly potent and selective agonists at the human A3 adenosine receptor.
J Med Chem. 2006 Jan 12;49(1):273-81. doi: 10.1021/jm050595e.
8
Stereoselective synthesis of beta-anomeric 4'-thiaspirocyclic ribonucleosides carrying the full complement of RNA-level hydroxyl substitution.
J Org Chem. 2005 Jul 8;70(14):5655-64. doi: 10.1021/jo0506985.
9
Structural determinants of efficacy at A3 adenosine receptors: modification of the ribose moiety.
Biochem Pharmacol. 2004 Mar 1;67(5):893-901. doi: 10.1016/j.bcp.2003.10.006.
10
N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor.
J Med Chem. 2003 Aug 28;46(18):3775-7. doi: 10.1021/jm034098e.
Zotero 插件